Lack of association of transforming growth factor-beta1 polymorphisms and haplotypes with prostate cancer risk in the prostate, lung, colorectal, and ovarian trial

Cancer Epidemiol Biomarkers Prev. 2007 Jun;16(6):1303-5. doi: 10.1158/1055-9965.EPI-06-0895.
No abstract available

Publication types

  • Clinical Trial

MeSH terms

  • Aged
  • Case-Control Studies
  • Female
  • Haplotypes
  • Humans
  • Male
  • Middle Aged
  • Polymorphism, Single Nucleotide*
  • Prostatic Neoplasms / genetics*
  • Risk Factors
  • Transforming Growth Factor beta1 / genetics*

Substances

  • Transforming Growth Factor beta1